JAZZ vs MRNA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 02, 2026

JAZZ

59.8
AI Score
VS
JAZZ Wins

MRNA

51.3
AI Score

Investment Advisor Scores

JAZZ

60score
Recommendation
HOLD

MRNA

51score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric JAZZ MRNA Winner
Revenue 1.07B 534.00M JAZZ
Net Income 293.10M -2.13B JAZZ
Net Margin 27.4% -397.9% JAZZ
Operating Income 336.60M -2.20B JAZZ
ROE 6.5% -31.4% JAZZ
ROA 2.5% -19.4% JAZZ
Total Assets 11.86B 10.96B JAZZ
Cash 1.84B 1.72B JAZZ
Debt/Equity 1.18 0.09 MRNA
Current Ratio 2.04 2.29 MRNA
Free Cash Flow 388.50M -1.25B JAZZ

Relative Price Performance (Last 90 Days)

JAZZ 1M: +6.5% · 3M: +24.5% MRNA 1M: -24.4% · 3M: +19.3%

Current Technical Phase

JAZZ

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.7% over 20 days), RSI 58

RSI (14): 57.9 · Price: $252.86

MRNA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 41

RSI (14): 40.6 · Price: $54.82

Fundamentals Snapshot

Metric JAZZ MRNA
Market Cap
Forward P/E 9.8 -11.5
Trailing P/E 2583.8
Revenue (TTM)
Revenue Growth 0.2% 2.6%
Gross Margin 0.9% -0.7%
Operating Margin 0.2% -1.3%
EPS 0.10 -8.14
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, JAZZ is currently the stronger investment candidate, winning 9 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.